586 related articles for article (PubMed ID: 23395877)
1. A pH-responsive nano-carrier with mesoporous silica nanoparticles cores and poly(acrylic acid) shell-layers: fabrication, characterization and properties for controlled release of salidroside.
Peng H; Dong R; Wang S; Zhang Z; Luo M; Bai C; Zhao Q; Li J; Chen L; Xiong H
Int J Pharm; 2013 Mar; 446(1-2):153-9. PubMed ID: 23395877
[TBL] [Abstract][Full Text] [Related]
2. Tailor-made pH-sensitive polyacrylic acid functionalized mesoporous silica nanoparticles for efficient and controlled delivery of anti-cancer drug Etoposide.
Saroj S; Rajput SJ
Drug Dev Ind Pharm; 2018 Jul; 44(7):1198-1211. PubMed ID: 29412022
[TBL] [Abstract][Full Text] [Related]
3. Reduction-responsive drug delivery based on mesoporous silica nanoparticle core with crosslinked poly(acrylic acid) shell.
Li H; Zhang JZ; Tang Q; Du M; Hu J; Yang D
Mater Sci Eng C Mater Biol Appl; 2013 Aug; 33(6):3426-31. PubMed ID: 23706230
[TBL] [Abstract][Full Text] [Related]
4. Fluorescent carbon dot modified mesoporous silica nanocarriers for redox-responsive controlled drug delivery and bioimaging.
Jiao J; Liu C; Li X; Liu J; Di D; Zhang Y; Zhao Q; Wang S
J Colloid Interface Sci; 2016 Dec; 483():343-352. PubMed ID: 27569517
[TBL] [Abstract][Full Text] [Related]
5. Designed fabrication of unique eccentric mesoporous silica nanocluster-based core-shell nanostructures for pH-responsive drug delivery.
Chen L; Li L; Zhang L; Xing S; Wang T; Wang YA; Wang C; Su Z
ACS Appl Mater Interfaces; 2013 Aug; 5(15):7282-90. PubMed ID: 23808730
[TBL] [Abstract][Full Text] [Related]
6. pH-responsive poly (acrylic acid)-gated mesoporous silica and its application in oral colon targeted drug delivery for doxorubicin.
Tian B; Liu S; Wu S; Lu W; Wang D; Jin L; Hu B; Li K; Wang Z; Quan Z
Colloids Surf B Biointerfaces; 2017 Jun; 154():287-296. PubMed ID: 28351801
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of poly (acrylic acid) modified mesoporous silica nanoparticles as pH response carrier for β-elemene self-micro emulsifying.
Yan B; Wang Y; Ma Y; Zhao J; Liu Y; Wang L
Int J Pharm; 2019 Dec; 572():118768. PubMed ID: 31669556
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of core-shell structured dual-mesoporous silica spheres with tunable pore size and controllable shell thickness.
Niu D; Ma Z; Li Y; Shi J
J Am Chem Soc; 2010 Nov; 132(43):15144-7. PubMed ID: 20939576
[TBL] [Abstract][Full Text] [Related]
9. Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release.
Zheng Q; Lin T; Wu H; Guo L; Ye P; Hao Y; Guo Q; Jiang J; Fu F; Chen G
Int J Pharm; 2014 Mar; 463(1):22-6. PubMed ID: 24393764
[TBL] [Abstract][Full Text] [Related]
10. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
Zhang Q; Zhao H; Li D; Liu L; Du S
Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
[TBL] [Abstract][Full Text] [Related]
11. pH-responsive mesoporous silica nanocarriers based on layer-by-layer self-assembly.
Zhang HY; Sun YF; Sun YL; Zhou M
Biomed Mater Eng; 2014; 24(6):2211-8. PubMed ID: 25226920
[TBL] [Abstract][Full Text] [Related]
12. Hybrid mesoporous silica nanospheres modified by poly (NIPAM-co-AA) for drug delivery.
Zhang K; Zhou D; Wang Z; Zhang Y; He P
Nanotechnology; 2019 Aug; 30(35):355604. PubMed ID: 31071691
[TBL] [Abstract][Full Text] [Related]
13. Preparation of pH-responsive mesoporous hydroxyapatite nanoparticles for intracellular controlled release of an anticancer drug.
Li D; Huang X; Wu Y; Li J; Cheng W; He J; Tian H; Huang Y
Biomater Sci; 2016 Feb; 4(2):272-80. PubMed ID: 26484364
[TBL] [Abstract][Full Text] [Related]
14. The thermal/pH-sensitive drug delivery system encapsulated by PAA based on hollow hybrid nanospheres with two silicon source.
Zhang K; Zhang Y; Li Y; Iqbal Z; Yu L; Liu J; Wang H; He P
J Biomater Sci Polym Ed; 2021 Apr; 32(6):695-713. PubMed ID: 33297850
[TBL] [Abstract][Full Text] [Related]
15. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of hollow mesoporous silica nanoparticles with tunable shell thickness and pore size using amphiphilic block copolymers as core templates.
Zhou X; Cheng X; Feng W; Qiu K; Chen L; Nie W; Yin Z; Mo X; Wang H; He C
Dalton Trans; 2014 Aug; 43(31):11834-42. PubMed ID: 24957865
[TBL] [Abstract][Full Text] [Related]
17. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
[TBL] [Abstract][Full Text] [Related]
18. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
Li T; Geng T; Md A; Banerjee P; Wang B
Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
[TBL] [Abstract][Full Text] [Related]
19. Targeted and controlled drug delivery by multifunctional mesoporous silica nanoparticles with internal fluorescent conjugates and external polydopamine and graphene oxide layers.
Tran AV; Shim K; Vo Thi TT; Kook JK; An SSA; Lee SW
Acta Biomater; 2018 Jul; 74():397-413. PubMed ID: 29775731
[TBL] [Abstract][Full Text] [Related]
20. Facile development, characterization, and evaluation of novel bicalutamide loaded pH-sensitive mesoporous silica nanoparticles for enhanced prostate cancer therapy.
Saroj S; Rajput SJ
Drug Dev Ind Pharm; 2019 Apr; 45(4):532-547. PubMed ID: 30582382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
